Looking Forward To A Bright Future
in Central New York
By Senator John A. DeFrancisco
Lately
many Central New Yorkers have pondered the future of Upstate
New York’s economic health. Some of you have asked what
is on the horizon to keep Central New York’s economy competitive
and thriving.
Upstate government and business leaders
have embarked on a promising project that could transform Central
New York into a leader in the Biotechnology industry. As a native
of Central New York, I know how vital unique economic development
opportunities are to our community and the residents. Job creation
continues to be one of my priorities as a State Senator, especially
during these challenging financial times. That is why I spearheaded
support for an $80 million Biotechnology Research Center which
will be built here in Syracuse.
In September, we announced $20 million
in support for phase one of the Biotechnology Research Center.
The Biotechnology Research Center was the brain child of officials
at SUNY Upstate Medical University and the SUNY College of Environmental
Science and Forestry.
The 240,000 square foot facility
will be completed in three phases and will include 40 research
laboratories, greenhouse facilities, conference centers, and
other high tech capabilities. Scientists and researchers will
focus on plant and animal biotechnology research which will
include DNA extraction and sequencing, bioinformatic tissue
engineering, and genotyping and genome mapping.
Bringing scientists from diverse
backgrounds together under one roof to exchange ideas could
lead to some ground breaking discoveries as well as major medical
breakthroughs. The possibilities are endless when it comes to
finding cures for diseases that are stumping health professionals
or improving and creating new pharmaceuticals that may ease
your own symptoms someday.
The project is unique in that it
will forge some unprecedented partnerships between the public
and private sectors. Some of Central New York’s most committed
business leaders have pledged their support for the project
including Welch-Allyn, Bristol-Myers Squibb, and O’Brien
and Gere.
The investment is expected to create
over 1,000 high tech, high paying jobs in Central New York.
The Center’s benefits will reach far beyond the walls
of the facility by spurring spin-off companies. These entrepreneurs
will have the opportunity to produce and market some of the
premiere discoveries born at the Biotechnology Center.
New businesses and innovative products
are a sure way to promote continued economic growth and an expanding
workforce in Central New York. Initiatives like this are the
types of ventures that will sustain our Central New York economy
for years to come and help to make our community a world leader
in a revolutionary field.
The
Feature Guest does not necessarily represent the views of the
TDO or it’s staff. It offers local and state legislators
an opportunity to express their viewpoints. If there is a legislator
you would like to see represented, please email: skuhns@tdo.org.